Understanding the biological function of CD133 expression as a CSC marker in pancreatic cancer will be helpful in elucidating its role in the pathogenesis of pancreatic cancer and developing more effective therapeutic approaches. The gene discussed is PROM1; the disease is pancreatic neoplasm.